Literature DB >> 19115375

Stimulation of NMDA and AMPA glutamate receptors elicits distinct concentration dynamics of nitric oxide in rat hippocampal slices.

J G Frade1, R M Barbosa, J Laranjinha.   

Abstract

Nitric oxide ((*)NO) is an intercellular messenger implicated in memory formation and neurodegeneration in the hippocampus. Owing to its physical and chemical properties, the concentration dynamics of (*)NO is a critical issue in determining its bioactivity as a signaling molecule. Its production is closely related to glutamate N-methyl-D-aspartate (NMDA) receptors, following a rise in intracellular calcium levels. However, that dependent on alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptors remains elusive and controversial, despite reports describing a role for these receptors in other brain regions, largely because of lack of quantitative and dynamic measurements of (*)NO. Using a (*)NO-selective microsensor inserted in the diffusional spread of (*)NO in the CA1 region of rat hippocampal slices, we measured its real-time endogenous production, following activation of ionotropic glutamate receptors and under tissue physiological oxygen tension. Both NMDA and AMPA stimulation resulted in a concentration-dependent (*)NO production but encompassing distinct kinetics for lag phases and slower rates of (*)NO production were observed for AMPA stimulation. Robustness of the results was achieved instrumentally and pharmacologically, by means of nitric oxide synthase (NOS) inhibitors and antagonists of NMDA (D-(-)-2-amino-5-phosphonopentanoic acid, AP5) and AMPA (2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide, NBQX) receptors. When using glutamate as a stimulus, (*)NO production was of lower magnitude in the presence of AP5 plus NBQX than with AP5 alone, suggesting that even when NMDA receptors are inhibited Ca(2+) rises to levels to induce a peak of (*)NO from the background. Whereas extracellular Ca(2+) was required for the (*)NO signals, Philanthotoxin-4,3,3 (PhTX-4,3,3) a toxin used to target Ca(2+)-permeable AMPA receptors, attenuated (*)NO production. These observations are interpreted on basis of a distinct coupling between the glutamate receptors and neuronal NOS. A role for Ca(2+)-permeable AMPA receptors in the Ca(2+) activation of neuronal NOS is suggested. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19115375     DOI: 10.1002/hipo.20536

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  11 in total

1.  Calcium-permeable α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors trigger neuronal nitric-oxide synthase activation to promote nerve cell death in an Src kinase-dependent fashion.

Authors:  Renato Socodato; Felipe N Santiago; Camila C Portugal; Ana F Domingues; Ana R Santiago; João B Relvas; António F Ambrósio; Roberto Paes-de-Carvalho
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

2.  Increased insertion of glutamate receptor 2-lacking alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors at hippocampal synapses upon repeated morphine administration.

Authors:  Sophie K Billa; Jie Liu; Nicole L Bjorklund; Namita Sinha; Yu Fu; Patricia Shinnick-Gallagher; Jose A Morón
Journal:  Mol Pharmacol       Date:  2010-02-16       Impact factor: 4.436

3.  Glutamate can act as a signaling molecule in mouse preimplantation embryos†.

Authors:  Alexandra Špirková; Veronika Kovaříková; Zuzana Šefčíková; Jozef Pisko; Martina Kšiňanová; Juraj Koppel; Dušan Fabian; Štefan Čikoš
Journal:  Biol Reprod       Date:  2022-10-11       Impact factor: 4.161

4.  Urban air pollutants reduce synaptic function of CA1 neurons via an NMDA/NȮ pathway in vitro.

Authors:  David A Davis; Garnik Akopian; John P Walsh; Constantinos Sioutas; Todd E Morgan; Caleb E Finch
Journal:  J Neurochem       Date:  2013-08-26       Impact factor: 5.372

Review 5.  Critical Evaluation of the Changes in Glutamine Synthetase Activity in Models of Cerebral Stroke.

Authors:  Thomas M Jeitner; Kevin Battaile; Arthur J L Cooper
Journal:  Neurochem Res       Date:  2015-08-02       Impact factor: 3.996

6.  Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease.

Authors:  Gjumrakch Aliev; Hector H Palacios; Amanda E Lipsitt; Kathryn Fischbach; Bruce T Lamb; Mark E Obrenovich; Ludis Morales; Eldar Gasimov; Valentin Bragin
Journal:  Neurotox Res       Date:  2009-05-30       Impact factor: 3.911

7.  Dynamic and interacting profiles of *NO and O2 in rat hippocampal slices.

Authors:  Ana Ledo; Rui Barbosa; Enrique Cadenas; João Laranjinha
Journal:  Free Radic Biol Med       Date:  2010-01-25       Impact factor: 7.376

8.  Picomolar nitric oxide signals from central neurons recorded using ultrasensitive detector cells.

Authors:  Katherine C Wood; Andrew M Batchelor; Katalin Bartus; Kathryn L Harris; Giti Garthwaite; Jeffrey Vernon; John Garthwaite
Journal:  J Biol Chem       Date:  2011-10-20       Impact factor: 5.157

9.  Nitric oxide inactivation mechanisms in the brain: role in bioenergetics and neurodegeneration.

Authors:  Ricardo M Santos; Cátia F Lourenço; Ana Ledo; Rui M Barbosa; João Laranjinha
Journal:  Int J Cell Biol       Date:  2012-06-10

10.  Cysteine 893 is a target of regulatory thiol modifications of GluA1 AMPA receptors.

Authors:  Lotta von Ossowski; Li-Li Li; Tommi Möykkynen; Sarah K Coleman; Michael J Courtney; Kari Keinänen
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.